Literature DB >> 24399557

Smoking prevalence and cigarette consumption in 187 countries, 1980-2012.

Marie Ng1, Michael K Freeman1, Thomas D Fleming1, Margaret Robinson1, Laura Dwyer-Lindgren1, Blake Thomson1, Alexandra Wollum1, Ella Sanman1, Sarah Wulf1, Alan D Lopez2, Christopher J L Murray1, Emmanuela Gakidou1.   

Abstract

IMPORTANCE: Tobacco is a leading global disease risk factor. Understanding national trends in prevalence and consumption is critical for prioritizing action and evaluating tobacco control progress.
OBJECTIVE: To estimate the prevalence of daily smoking by age and sex and the number of cigarettes per smoker per day for 187 countries from 1980 to 2012.
DESIGN: Nationally representative sources that measured tobacco use (n = 2102 country-years of data) were systematically identified. Survey data that did not report daily tobacco smoking were adjusted using the average relationship between different definitions. Age-sex-country-year observations (n = 38,315) were synthesized using spatial-temporal gaussian process regression to model prevalence estimates by age, sex, country, and year. Data on consumption of cigarettes were used to generate estimates of cigarettes per smoker per day. MAIN OUTCOMES AND MEASURES: Modeled age-standardized prevalence of daily tobacco smoking by age, sex, country, and year; cigarettes per smoker per day by country and year.
RESULTS: Global modeled age-standardized prevalence of daily tobacco smoking in the population older than 15 years decreased from 41.2% (95% uncertainty interval [UI], 40.0%-42.6%) in 1980 to 31.1% (95% UI, 30.2%-32.0%; P < .001) in 2012 for men and from 10.6% (95% UI, 10.2%-11.1%) to 6.2% (95% UI, 6.0%-6.4%; P < .001) for women. Global modeled prevalence declined at a faster rate from 1996 to 2006 (mean annualized rate of decline, 1.7%; 95% UI, 1.5%-1.9%) compared with the subsequent period (mean annualized rate of decline, 0.9%; 95% UI, 0.5%-1.3%; P = .003). Despite the decline in modeled prevalence, the number of daily smokers increased from 721 million (95% UI, 700 million-742 million) in 1980 to 967 million (95% UI, 944 million-989 million; P < .001) in 2012. Modeled prevalence rates exhibited substantial variation across age, sex, and countries, with rates below 5% for women in some African countries to more than 55% for men in Timor-Leste and Indonesia. The number of cigarettes per smoker per day also varied widely across countries and was not correlated with modeled prevalence. CONCLUSIONS AND RELEVANCE: Since 1980, large reductions in the estimated prevalence of daily smoking were observed at the global level for both men and women, but because of population growth, the number of smokers increased significantly. As tobacco remains a threat to the health of the world's population, intensified efforts to control its use are needed.

Entities:  

Mesh:

Year:  2014        PMID: 24399557     DOI: 10.1001/jama.2013.284692

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  518 in total

1.  Gender, depressive symptoms, and daily cigarette use.

Authors:  Cristina B Bares
Journal:  J Dual Diagn       Date:  2014

Review 2.  Advancing Tobacco Dependence Treatment Services in the Eastern Mediterranean Region: International collaboration for training and capacity-building.

Authors:  Feras I Hawari; Rasha K Bader
Journal:  Sultan Qaboos Univ Med J       Date:  2014-10-14

3.  The impact of genetic variation and cigarette smoke on DNA methylation in current and former smokers from the COPDGene study.

Authors:  Weiliang Qiu; Emily Wan; Jarrett Morrow; Michael H Cho; James D Crapo; Edwin K Silverman; Dawn L DeMeo
Journal:  Epigenetics       Date:  2015       Impact factor: 4.528

4.  Smoking and projected cardiovascular risk in an HIV-positive Asian regional cohort.

Authors:  T C Do; D Boettiger; M Law; S Pujari; F Zhang; R Chaiwarith; S Kiertiburanakul; M P Lee; R Ditangco; W W Wong; K V Nguyen; T P Merati; T T Pham; A Kamarulzaman; S Oka; E Yunihastuti; N Kumarasamy; P Kantipong; J Y Choi; O T Ng; N Durier; K Ruxrungtham
Journal:  HIV Med       Date:  2016-08       Impact factor: 3.180

5.  Smoking Trajectories during the Perinatal Period and Their Risk Factors: The Nationally Representative French ELFE (Etude Longitudinale Française Depuis l'Enfance) Birth Cohort Study.

Authors:  Fabienne El-Khoury; Anne-Laure Sutter-Dallay; Judith Van Der Waerden; Pamela Surkan; Silvia Martins; Katherine Keyes; Blandine de Lauzon-Guillain; Marie-Aline Charles; Maria Melchior
Journal:  Eur Addict Res       Date:  2017-09-02       Impact factor: 3.015

Review 6.  Global trends of lung cancer mortality and smoking prevalence.

Authors:  Farhad Islami; Lindsey A Torre; Ahmedin Jemal
Journal:  Transl Lung Cancer Res       Date:  2015-08

Review 7.  Relation of active, passive, and quitting smoking with incident type 2 diabetes: a systematic review and meta-analysis.

Authors:  An Pan; Yeli Wang; Mohammad Talaei; Frank B Hu; Tangchun Wu
Journal:  Lancet Diabetes Endocrinol       Date:  2015-09-18       Impact factor: 32.069

Review 8.  An international smoking ban-how many lives will be saved?

Authors:  Cecily C Kelleher; Kate Frazer
Journal:  Curr Atheroscler Rep       Date:  2014-06       Impact factor: 5.113

Review 9.  Stress is a principal factor that promotes tobacco use in females.

Authors:  Oscar V Torres; Laura E O'Dell
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2015-04-22       Impact factor: 5.067

10.  Cadmium exposure enhances organic cation transporter 2 trafficking to the kidney membrane and exacerbates cisplatin nephrotoxicity.

Authors:  Hong Yang; Jie Tang; Dong Guo; Qingqing Zhao; Jiagen Wen; Yanjuan Zhang; Obinna N Obianom; Shiwei Zhou; Wei Zhang; Yan Shu
Journal:  Kidney Int       Date:  2019-11-26       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.